Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 3 Recurrence 1 Osteosarcoma 1 Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Breast Neoplasms 1

Interventions

Gemcitabine 21 Cisplatin 16 durvalumab 12 lenvatinib 11 Oxaliplatin 11 pembrolizumab 6 Liver Transplantation 4 Leucovorin 4 Floxuridine 4 tislelizumab 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Folfox protocol 3 Fluorouracil 3 Drug Therapy 3 Capecitabine 3 Biopsy 3 tremelimumab 2 pemigatinib 2 olaparib 2 ivosidenib 2 irinotecan sucrosofate 2 apatinib 2 Taxes 2 Specimen Handling 2 Injections 2 Immunoglobulin G 2 Immune Checkpoint Inhibitors 2 Fluorodeoxyglucose F18 2 Disulfides 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Cholangiocarcinoma × Clinical Protocols × Clear all

NCT05557578 2025-02-11

GOT

Zhejiang Cancer Hospital

Phase 2 Recruiting

Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡